Recap: Maravai LifeSciences Q4 Earnings

Maravai LifeSciences (NASDAQ:MRVI) reported its Q4 earnings results on Thursday, February 22, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Maravai LifeSciences beat estimated earnings by 200.0%, reporting an EPS of $0.01 versus an estimate of $-0.01.

Revenue was down $130.57 million from the same period last year.

Last quarter the company missed on EPS by $0.02 which was followed by a 31.69% drop in the share price the next day.

Here's a look at Maravai LifeSciences's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	0.01	0.01	0.04	0.34
EPS Actual	-0.01	0	0.03	0.35
Revenue Estimate	75.52M	70.30M	79.72M	204.93M
Revenue Actual	66.86M	68.91M	79.03M	204.71M

To track all earnings releases for Maravai LifeSciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.